A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
Sistani joined WeightWatchers as CEO more than two years ago. During her tenure, she led the company's recent moves into the ...
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...
WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...
Revolutionary weight-loss injections such as Wegovy and Ozempic reduce the risk of some of the most common and deadly cancers, a major study suggests. Obese patients taking the drugs, which were ...